Robert Carey Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Robert Carey is EVP, Chief Business Officer of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 17,267 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Mar 23, 2019, when has been sold 13,733 shares (Ordinary Shares) at a price of $26.84 per share, resulting in proceeds of $368,594. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.3K

0% 3M change

0% 12M change

Total Value Held $0

Robert Carey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 23 2019	SELL Payment of exercise price or tax liability	$368,594 $26.84 p/Share	13,733 Reduced 44.3%	17,267 Ordinary Shares
Mar 23 2019	BUY Exercise of conversion of derivative security	-	31,000 Added 50.0%	31,000 Ordinary Shares
Feb 20 2019	SELL Payment of exercise price or tax liability	$690,659 $21.54 p/Share	32,064 Reduced 44.3%	40,311 Ordinary Shares
Feb 20 2019	BUY Grant, award, or other acquisition	-	72,375 Added 50.0%	72,375 Ordinary Shares
Jan 05 2019	SELL Payment of exercise price or tax liability	$599,853 $20.39 p/Share	29,419 Reduced 44.78%	36,276 Ordinary Shares
Jan 05 2019	BUY Exercise of conversion of derivative security	-	65,695 Added 50.0%	65,695 Ordinary Shares
Mar 23 2018	SELL Payment of exercise price or tax liability	$125,890 $13.86 p/Share	9,083 Reduced 18.85%	39,106 Ordinary Shares
Mar 23 2018	BUY Exercise of conversion of derivative security	-	31,000 Added 39.15%	48,189 Ordinary Shares
Mar 05 2018	SELL Payment of exercise price or tax liability	$219,024 $15.83 p/Share	13,836 Reduced 44.6%	17,189 Ordinary Shares
Mar 05 2018	BUY Exercise of conversion of derivative security	-	31,025 Added 50.0%	31,025 Ordinary Shares
Mar 23 2017	SELL Payment of exercise price or tax liability	$206,272 $14.56 p/Share	14,167 Reduced 29.3%	34,190 Ordinary Shares
Mar 23 2017	BUY Exercise of conversion of derivative security	-	31,000 Added 39.06%	48,357 Ordinary Shares
Mar 05 2017	SELL Payment of exercise price or tax liability	$229,857 $16.11 p/Share	14,268 Reduced 45.12%	17,357 Ordinary Shares
Mar 05 2017	BUY Exercise of conversion of derivative security	-	31,025 Added 49.52%	31,625 Ordinary Shares
Mar 23 2016	SELL Payment of exercise price or tax liability	$231,205 $16.32 p/Share	14,167 Reduced 27.03%	38,242 Ordinary Shares
Mar 23 2016	BUY Exercise of conversion of derivative security	-	31,000 Added 37.17%	52,409 Ordinary Shares
Mar 05 2016	SELL Payment of exercise price or tax liability	$161,356 $16.78 p/Share	9,616 Reduced 30.99%	21,409 Ordinary Shares
Mar 05 2016	BUY Exercise of conversion of derivative security	-	31,025 Added 50.0%	31,025 Ordinary Shares
Feb 19 2016	SELL Bona fide gift	-	24,406 Reduced 100.0%	0 Ordinary Shares
Mar 05 2015	SELL Payment of exercise price or tax liability	$202,898 $20.84 p/Share	9,736 Reduced 29.52%	23,245 Ordinary Shares
Mar 05 2015	BUY Exercise of conversion of derivative security	-	31,025 Added 48.47%	32,981 Ordinary Shares

Also insider at

XAIR

Beyond Air, Inc. Healthcare

Director

SGMO

SANGAMO THERAPEUTICS, INC Healthcare

Robert Carey

EVP, Chief Business Officer

Dublin, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Value

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

Operation

Value

Type

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP

Account